3 Nov 2025
Stop by poster #H029 presented by Paulina Gomez at the #AMPath2025 poster session on November 15 from 9:15-10:15 AM to learn about our AML testing services.
Visit hubs.li/Q03RpwBg0 to learn more about MyAML and MyMRD.
#LabPMM #AML #GenePanels #MRD
1
5
231
31 Jul 2025
We are pleased to share a recent publication from #LabPMM, covering interpretation, tracking and reporting of #KMT2A fusions in #AML. Read the full publication here: hubs.li/Q03zPZC20
#MeninInhibitors #Drugdevelopment #MyMRD #MyAML
1
4
71
2 Jul 2025
ＮＰＭ１・ＭＲＤアッセイの承認取得＝インビボスクライブ〔ＢＷ〕
【ビジネスワイヤ】垂直統合型バイオテクノロジー企業の米インビボスクライブは、同社の完全子会社であるＬａｂＰＭＭが、ニューヨーク州からＮＰＭ１・ＭＲＤアッセイの承認を取得した…
medical.jiji.com/news/60407
1
2
1,793
30 Apr 2025
ＦＬＴ３・ＩＴＤ・ＭＲＤアッセイの承認取得＝インビボスクライブ〔ＢＷ〕
【ビジネスワイヤ】垂直統合型バイオテクノロジー企業の米インビボスクライブは、完全子会社であるＬａｂＰＭＭが、ニューヨーク州保健局からＦＬＴ３・ＩＴＤ・ＭＲＤアッセイ…
medical.jiji.com/news/60167
1
3
1,883
21 Apr 2025
We’re uniting brilliant minds to develop globally standardized testing that advances precision healthcare for those affected by AML. Click here to learn more about our hemato-oncology products: hubs.li/Q03hGJ1K0
#KnowAML #AML #Invivoscribe #LabPMM #FLT3 #NPM1 #MRD
3
74
1 Jun 2024
We are at #ASCO24! Join us again tomorrow from 9 am at booth 34087 to learn about our ultra-sensitive globally standardized flow & molecular services offered at our global network of accredited labs #LabPMM
#MRD #MFC #CDx #OncologyResearch #PrecisionMedicine
1
3
76
31 May 2024
Visit us TOMORROW at #ASCO24 to learn about our ultra-sensitive globally standardized flow & molecular services offered at our global network of accredited labs #LabPMM #MRD #MFC #CDx #OncologyResearch #PrecisionMedicine
2
2
59
28 May 2024
Visit us at #ASCO24, #EHA2024, and #AMPEurope2024 to learn about our ultra-sensitive globally standardized flow & molecular services offered at our global network of accredited labs #LabPMM #MRD #MFC #CDx #OncologyResearch #PrecisionMedicine
3
2
3
87
1 Mar 2023
March is #MyelomaACTIONMonth! We invite you to share your #MYelomaSTORY. Invivoscribe is dedicated to improving lives with precision diagnostics. If you’d like to help us make a difference, join our team. Apply today: hubs.li/Q01DS5Cy0
#myeloma #invivoscribe #labpmm
1
3
4
453
1 Feb 2023
Invivoscribe is excited to announce the appointment of Masato Sasaki as General Manager of LabPMM GK, our reference laboratory in Japan. READ THE PRESS RELEASE: hubs.li/Q01z-zpP0
2
117
4 Nov 2022
We're here at booth #931 for day two of #AMPath22! Come by to learn about the new FLT3 ITD MRD Assay we offer for your in-house AML MRD research needs! #invivoscribe #LabPMM #AML #FLT3
ALT Talk to us about our FLT3 ITD MRD Assay at booth #931!
3
28 Oct 2022
Join our AMP corporate workshops on Nov. 2nd to learn about our hemato-oncology solutions from our collaborators from Stanford University and Roswell Park Comprehensive Cancer Center. #invivoscribe #LabPMM #AMPath22
1
2
23 Jun 2022
Don't miss our Senior Director of Product Development’s talk at #PMWC22 about our “Comprehensive Solution for AML Precision Diagnostics.” To learn more about our solution and other LabPMM services, visit booth C2020 to talk to our experts, or visit: hubs.ly/Q01fqd2N0
1
2
16 Jun 2022
We’ll see you at #PMWC22! Don't miss our talk about our “Comprehensive Solution for AML Precision Diagnostics.” If you want to learn more about our solution and other LabPMM services, visit booth C2020! You can also visit: hubs.ly/Q01dQwhN0
1
1
10 Jun 2022
We are at #EHA2022 in Vienna! Join us today at 4:30 pm at a poster session to learn from our expert about Invivoscribe’s new B-cell MRD Assay performance.
See you at the poster number P1263.
#invivoscribe #LabPMM #MRD #EHA
2
3 May 2022
How does YOUR Clonality Testing compare? Watch Invivoscribe's FREE webinar on Thursday, May 19th with Dr. Rena Xian from Johns Hopkins School of Medicine to find out! REGISTER FOR FREE TODAY: ow.ly/jkpf50IK3Ge #invivoscribe #labpmm #NGS
1
31 Mar 2022
For over 25 years Invivoscribe has been supporting and providing diagnostics to clinicians, researchers, and laboratories to improve the lives of patients around the world.
Learn more: invivoscribe.com/diseases/he…
#MYelomaACTION #invivoscribe #LabPMM #myeloma
1
1
1 Mar 2022
March is Myeloma Action Month. For over 25 years Invivoscribe has been providing diagnostics to clinicians, researchers, and laboratories to improve the lives of patients around the world. Learn more: invivoscribe.com/diseases/he… #MYelomaACTION #invivoscribe #LabPMM #myeloma
3
4
12 Nov 2020
Make sure to watch our very own Chief Medical Officer, Dr. Bradley Patay speak about, "Artificial Intelligence (AI) and other Data Science Applications in Molecular Pathology!" This #AMPath20 workshop will be available On-Demand on Nov. 16th! #invivoscribe #labpmm
1
3
3